首页> 外文期刊>Schizophrenia bulletin >Using state administrative and pharmacy data bases to develop a clinical decision support tool for schizophrenia guidelines.
【24h】

Using state administrative and pharmacy data bases to develop a clinical decision support tool for schizophrenia guidelines.

机译:使用州行政管理和药房数据库开发针对精神分裂症指南的临床决策支持工具。

获取原文
获取原文并翻译 | 示例
           

摘要

Administrative and pharmacy data bases represent a largely untapped resource for clinical decision support and quality improvement. In this study, we examined the feasibility of using New York State Office of Mental Health (NYSOMH) data bases to develop an automated clinical report to support implementation of schizophrenia guidelines. First we reviewed the structure of existing data bases for capacity and limitations in supporting guideline implementation. Second, we identified schizophrenia guideline recommendations and adherence measures that would be the focus of our implementation. Third, a preliminary report was programmed, based on operational definitions of the guideline recommendations. Finally, we developed user groups to define content and format of new reports, through an iterative process of field testing, feedback, and revision. Our experience suggests that administrative and pharmacy data bases, despite their limitations, can be used to develop guideline-based clinical decision support tools for schizophrenia with high physician acceptability.
机译:行政和药学数据库代表了临床决策支持和质量改善方面尚未开发的资源。在这项研究中,我们研究了使用纽约州精神卫生办公室(NYSOMH)数据库开发自动临床报告以支持精神分裂症指南实施的可行性。首先,我们回顾了现有数据库的结构,以了解支持指南实施的能力和局限性。其次,我们确定了精神分裂症指南的建议和依从性措施,这将是我们实施的重点。第三,根据准则建议的业务定义编制了一份初步报告。最后,我们通过现场测试,反馈和修订的迭代过程,开发了用户组来定义新报告的内容和格式。我们的经验表明,尽管行政管理和药学数据库存在局限性,但仍可用于开发基于指南的精神分裂症临床决策支持工具,具有很高的医生接受度。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号